Radiolabeling of [ 18F]altanserin - a microfluidic approach

Nuclear Medicine and Biology

Volumn 39, Issue 7, 2012, Pages 1087-1092

  Ungersboeck, Johanna ^a,b   Richter, Sandra ^a,b   Collier, Lee ^c   Mitterhauser, Markus ^a,b   Karanikas, Georgios ^a   Lanzenberger, Rupert ^a   Dudczak, Robert ^a   Wadsak, Wolfgang ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Advion BioSciences Inc   (United States)

Author keywords

5 HT; Fluorine 18; Microfluidics; PET; Receptor; Serotonin

Indexed keywords

ALTANSERIN F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ALTANSERIN; DRUG DERIVATIVE; FLUORINE; KETANSERIN;

ARTICLE; CHEMICAL REACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ISOTOPE LABELING; MICROFLUIDICS; PROCESS OPTIMIZATION; RADIOCHEMICAL INCORPORATION YIELD; RADIOCHEMISTRY; SCALE UP; CHEMISTRY; INSTRUMENTATION; MICROFLUIDIC ANALYSIS; TEMPERATURE;

FLUORINE RADIOISOTOPES; ISOTOPE LABELING; KETANSERIN; MICROFLUIDIC ANALYTICAL TECHNIQUES; RADIOCHEMISTRY; TEMPERATURE;

EID: 84866049181     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.04.004     Document Type: Article

References (22)

1. Elizarov A.M. Microreactors for radiopharmaceutical synthesis. Lab Chip 2009, 9:1326-1333.
2. Lu S.Y., Watts P., Chin F.T., Hong J., Musachio J.L., Briard E., et al. Syntheses of 11C- and 18F-labeled carboxylic esters within a hydrodynamically-driven micro-reactor. Lab Chip 2004, 4:523-525.
3. Pascali G., Mazzone G., Saccomanni G., Manera C., Salvadori P.A. Microfluidic approach for fast labeling optimization and dose-on-demand implementation. J Nucl Med Biol 2010, 37:547-555.
4. Brady F., Luthra S.K., Gillies J.M., Jeffery N.T. Use of microfabricated devices for radiosynthesis of radiotracers for positron emission tomography 2003, Imaging Research Solutions Ltd., UK, [Patent: WO 03/078358].
5. Lee C.C., Sui G., Elizarov A., Shu C.J., Shin Y.S., Dooley A.N., et al. Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics. Science 2005, 310:1793-1796.
6. Gillies J.M., Prenant C., Chimon G.N., Smethurst G.J., Dekker B.A., Zweit J. Microfluidic technology for PET radiochemistry. Appl Radiat Isot 2006, 64:333-336.
7. Steel C.J., O'Brien A.T., Luthra S.K., Brady F. Automated PET radiosyntheses using microfluidic devices. J Labelled Compd Radiopharm 2007, 50:308-311.
8. Gillies J.M., Prenant C., Chimon G.N., Smethurst G.J., Perrie W., Hamblett I., et al. Microfluidic reactor for the radiosynthesis of PET radiotracers. Appl Radiat Isot 2006, 64:325-332.
9. 18F]fallypride in a micro-reactor: rapid optimization and multiple-production in small doses for micro-PET studies. Curr Radiopharma. 2009, 2:49-55.
10. Briard E., Zoghbi S.S., Simeon F.G., Imaizumi M., Gourley J.P., Shetty H.U., et al. Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET. J Med Chem 2009, 52:688-699.
11. Chun J.-H., Lu S., Lee Y.-S., Pike V.W. Fast and high-yield microreactor syntheses of ortho-substituted [18F]fluoroarenes from reactions of [18F]fluoride ion with diaryliodonium salts. J Org Chem 2010, 75:3332-3338.
12. Leysen J.E. Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites. Drugs as Tools in Neurotransmitter research. Neuromethods 1989, Vol. 12:299-350. Human Press, Clifton, New Jersey. A.B. Boulton, G.B. Baker, A.V. Juris (Eds.).
13. Tan P.Z., Baldwin R.M., Van Dyck C.H., Al-Tikriti M., Roth B., Khan N., et al. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent. Nucl Med Biol 1999, 26:601-608.
14. Hasler F., Kuznetsova O.F., Krasikova R.N., Cservenyak T., Quednow B.B., Vollenweider F.X., et al. GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies. Appl Radiat Isot 2009, 67:598-601.
15. Tan P.-Z., Baldwin R.M., Fu T., Charney D.S., Innis R.B. Rapid synthesis of F-18 and H-2 dual-labeled altanserin, a metabolically resistant PET ligand for 5-HT2a receptors. J Labelled Compd Radiopharm 1999, 42:457-467.
16. Massarweh G., Kovacevic M., Rosa-Neto P., Evans A.C., Diksic M., Schirrmacher R. Time-efficient and convenient synthesis of [18F]altanserin for human PET imaging by a new work-up procedure. Appl Radiat Isot 2009, 67:2040-2043.
17. Monclus M., Van Naemen J., Mulleneers E., Damhaut P., Luxen A., Goldman S. Automatic synthesis of [18F]altanserin, a radiopharmaceutical for positron emission tomographic studies of the serotonergic type-2 receptors. Clinical Positron Imaging 1998, 1:111-116.
18. Lemaire C., Cantineau R., Guillaume M., Plenevaux A., Christiaens L. Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med 1991, 32:2266-2272.
19. Hamacher K., Coenen H.H. No-carrier-added nucleophilic 18F-labelling in an electrochemical cell exemplified by the routine production of [18F]altanserin. Appl Radiat Isot 2006, 64:989-994.
20. Ungersboeck J., Philippe C.C., Mien L.-K., Haeusler D., Shanab K., Lanzenberger R., et al. Microfluidic preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2: a comparison with conventional radiosyntheses. Nucl Med Biol 2010, 38:427-434.
21. Riss P.J., Hong Y.T., Williamson D., Caprioli D., Sitnikov S., Ferrari V., et al. Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling. J Cereb Blood Flow Metab 2011, 31:2334-2342.
22. Tan P.-Z., Baldwin R.M., Soufer R., Garg P.K., Charney D.S., Innis R.B. A complete remote-control system for reliable preparation of [18F]altanserin. Appl Radiat Isot 1999, 50:923-927.